Ananda Developments - Quarterly Trading Statement to 30 April 2024
RNS
Latest announcements
Announcement summary
Ananda Developments - Quarterly Trading Statement to 30 April 2024
Ananda Developments Plc (AQUIS: ANA), the company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of chronic, complex inflammatory pain conditions, announces its unaudited Company management statements for the quarter ended 30 April 2024.
Ask a question
Your question will be sent privately to Ananda Pharma. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Ananda Pharma a question about this announcement.